HIBA PHARMA

000

KEZAD, Abu Dhabi

Est. 2021

Therapeutic Portfolio

Therapeutic Portfolio

Six Areas of Therapeutic Precision

Our pipeline spans six high-priority therapeutic domains, from oncology sterile injectables to next-generation immunology formulations.

Therapeutic Portfolio

Six Domains.
One Standard.

01 / 06

Oncology

Specialized treatments and life-saving sterile injectable cancer therapies that improve patient outcomes. UAE's only local sterile oncology manufacturer.

StatusActive Pipeline
Dosage FormsSterile Injectable, Oral
Oncology
02 / 06

Critical Care

Essential pharmaceutical solutions addressing critical healthcare challenges with precision formulation and rapid response capabilities.

StatusActive Pipeline
Dosage FormsOral, Topical
Critical Care
03 / 06

Hormone

Advanced hormonal therapies formulated to restore balance and support long-term metabolic and endocrine health.

StatusActive Pipeline
Dosage FormsOral, Topical
Hormone
04 / 06

Cardiovascular

Next-generation therapies focused on improving cardiovascular health and extending patient longevity.

StatusActive Pipeline
Dosage FormsOral, Topical
Cardiovascular
05 / 06

CNS

Targeted biologic therapies engineered to modulate the central nervous system with precision and efficacy.

StatusActive Pipeline
Dosage FormsOral, Topical
CNS
06 / 06

Metabolic Disorders

Innovative pharmaceutical solutions for complex metabolic and diabetic conditions.

StatusActive Pipeline
Dosage FormsOral, Topical
Metabolic Disorders